Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases
Majority of Invasive Bladder Cancer Patients Do Not Receive Full Recommended Care
Pertuzumab Delays Progression In HER2-Positive Breast Cancer
Sentinel Lymph Node Excision Has No Impact on Survival
Increased Breast Density Can Lead to Higher Risk
Computer Interpretation Software Does Not Improve Detection
Bone Marrow Transplant Survival Has Doubled In Young Patients
Two Studies Demonstrate Molecule Blocking Cell Damage
Interim Analysis Suggests Paclical Can Reduce Blood Levels
Hormone Therapy Can Reduce Survival In Men With Heart Problems
Zometa Can Reduce Risk Of Skeletal-Related Events
Cell Phone Radiation Does Not Raise Child’s Risk of Tumors
Clinical Trials Approved by NCI CTEP Last Month
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - Ian Krop named section chief of Medical Oncology and Hematology and deputy director for Clinical Affairs at Yale
